Prevalence and characteristics of coronary microvascular dysfunction in post-percutaneous coronary intervention

Lijun Cui1,2, Liju Han1,2, Jiao Wang2,3

  • 1Department of Cardiology, TEDA International Cardiovascular Hospital, Tianjin, China.

Insights

Coronary microvascular dysfunction (CMD) is prevalent in patients with recurrent chest pain after percutaneous coronary intervention (PCI). Increased BMI and LDL-C are independent predictors of CMD, highlighting the need for targeted management strategies.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Diagnostic Imaging

Background:

  • Coronary microvascular dysfunction (CMD) and obstructive coronary artery disease (CAD) often coexist, potentially causing persistent angina after revascularization.
  • Evaluating CMD in patients with recurrent chest pain post-PCI is crucial for understanding treatment limitations.

Purpose of the Study:

  • To determine the prevalence and characteristics of CMD in patients experiencing recurrent chest pain after undergoing percutaneous coronary intervention (PCI).

Main Methods:

  • A retrospective cross-sectional study involving 102 patients who had previously undergone PCI and presented with recurrent chest pain.
  • Coronary angiography and myocardial perfusion imaging (MPI) were used to assess stenosis and myocardial flow reserve (MFR).
  • CMD was defined at the vascular level (stenosis <50% with MFR <2.0) and participant level (non-obstructive coronary arteries with vascular-level CMD).

Main Results:

  • The prevalence of CMD was 43.1% at the vascular level and 49.0% of patients had coexisting CAD and CMD.
  • Patients with CMD exhibited higher BMI, total cholesterol, and LDL-C compared to controls.
  • Significantly reduced stress myocardial blood flow (MBF) was observed in CMD patients (1.36±0.43 vs. 2.50±0.70, P<0.01).
  • Increased BMI (OR: 1.405) and LDL-C (OR: 3.094) were independently correlated with CMD.

Conclusions:

  • Coronary microvascular dysfunction (CMD) is common in post-PCI patients with recurrent angina.
  • Elevated BMI and LDL-C are independent predictors of CMD in this patient population.
  • These findings underscore the importance of considering and managing CMD in patients with persistent angina post-revascularization.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
43
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
48
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
34
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
61
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
44
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
41